Salivary histatins in patients with recurrent oral candidiasis

Journal of Oral Pathology and Medicine

Volumn 28, Issue 1, 1999, Pages 26-29

  Bercier, John G ^a   Al Hashimi, Ibtisam ^a   Haghighat, Nasser ^a   Rees, Terry D ^a   Oppenheim, Frank G ^b  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Candidiasis; Histatins; Saliva

Indexed keywords

EID: 0032888940     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb01990.x     Document Type: Article

References (23)

1. THOMAS I. Superficial and deep candidosis. Int J Dermatol 1993; 32: 778-83.
2. FOTOS PG, HELLSTEIN JW. Candida and candidosis. Epidemiology, diagnosis, and therapeutic management. Dent Clin North Am 1992; 36: 857-78.
3. EPSTEIN JB, PEARSALL NN, TRULOVE EL. Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. J Clin Microbiol 1980; 12: 475-6.
4. MANDEL ID, BARR CE, TURGEON L. Longitudinal study of parotid saliva in HIV-1 infection. J. Oral Pathol Med 1992; 21: 209-13.
5. JORGE AO, TOTTI MA, DE ALMEIDE OP, SCULLY C. Effect of sialoadenectomy on the carriage of Candida albicans in mouths of rats. J Oral Pathol Med 1993; 22: 138-40.
6. POLLOCK JJ, DENEPITIYA L, MACKAY BJ, IACONO VJ. Fungistatic and fungicidal activity of human parotid salivary histidine rich polypeptides on C. albicans. Infect Immun 1984; 44: 702-7.
7. OPPENHEIM FG. Salivary histidine-rich proteins. In: Human saliva: clinical chemistry and microbiology, vol. 1. Boca Raton, Florida: CRC Press, 1989; 151-60.
8. CHALLACOMBE S. Immunologic aspects of oral candidiasis. Oral Surg Oral Med Oral Pathol 1994; 78: 202-10.
9. OPPENHEIM FG, XU T, MCMILLIAN FM, et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 1988; 263: 7472-7.
10. TROXLER RF, OFFNER GD, XU T, VANDERSPEK JC, OPPENHEIM FG. Structural relationship between human salivary histatins. J Dent Res 1990; 69: 2-6.
11. SCHENKELS LC, VEERMAN EC, AMERORGEN AV. Biochemical composition of human saliva in relation to other mucosal fluids. Crit Rev Oral Biol Med 1995; 6: 161-75.
12. RAJ PA, EDGERTON ME, LEVINE MJ. Salivary histatin 5: dependence on sequence, chain length, and helical conformation for candidacidal activity. J Biol Chem 1990; 265: 3898-905.
13. ATKINSON JC, YEH C, OPPENHEIM FG, BERMUDEZ D, BAUM BJ, FOX PC. Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1990; 3: 41-8.
14. LAL K, POLLOCK JJ, SANTARPIA RP, et al. Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. J Acquir Immune Defic Syndr Hum Retrovirol 1992; 5: 904-14.
15. NAJERA M, AL-HASHIMI I, PLEMONS J, RIVERA-HIDALGO F, REES TD, HAGHIGHAT, N. Prevalence of periodontal disease in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1997; 83: 453-7.
16. SMITH PK, KROHNG RI, HERMANSON T, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
17. LUNDY FT, AL-HASHIMI I, LAMY P-J, REES TD. Evaluation of major parotid glycoproteins in patients with burning mouth. Oral Surg Med Pathol 1997; 83: 252-8.
18. OPPENHEIM FG, YANG Y-C, DIAMOND RD, HYSLOP D, OFFNER GD, TROXLER RF. The primary structure and functional characterization of neutral histidine-rich polypeptide from human secretion. J Biol Chem 1986; 261: 1177-82.
19. JENSEN JL, XU T, LAMKIN MS, et al. Physiological regulation of the secretion of histatins and statherins in human parotid saliva. J Dent Res 1994; 73: 1811-7.
20. MACKA BJ, POLLOCK JJ, IACONO VJ, BAUM BJ. Isolation of milligram quantities of a group of histidine-rich polypeptides from human parotid saliva. Infect Immun 1984; 44: 688-94.
21. BAUM BJ, BIRD JL, MILLAR DB, LONGTOX RW. Studies on histidine-rich polypeptides from human parotid saliva. Arch Biochem Biophys 1976; 177: 427-36.
22. SANTARPIA RP, CHO M-I, POLLOCK JJ. Parameters affecting the inhibition of Candida albicans GDH 2023 and GRI 2773 blastospore viability by purified synthetic salivary histidine-rich polypeptides. Oral Microbiol Immunol 1990; 5: 226-32.
23. BRANT EC, SANTARPIA RP, POLLOCK JJ. The role of pH in salivary histidine rich polypeptide antifungal germ tube inhibitory activity. Oral Microbiol Immunol 1990; 5: 336-9.